A pilot study of using 25 mg BD sacubitril/valsartan effect in reverse LV remodeling: A single-center experience. (December 2022) - Othman, M.K.; Yusof, Z.; Wu, J.T.; Ibrahim, S.; Ismail, M.F.; MAM, Ismail; Zakaria, A.Z.; Hussin, S.A.; NAH, Nik Mohd Zaid; Zakaria, S.; Isa, W.Y.H.W.